Study of Aspirin and Exemestane as Adjuvant Treatment in Breast Cancer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
This is a phase II study to assess efficacy/safety of Exemestane with or without Aspirin as the adjuvant treatment in postmenopausal breast cancer patients.
Epistemonikos ID: 73e1c32190770b2a8eb69227c131dc21f4651dca
First added on: May 06, 2024